The International BRCA Forum (iBRCAf) is a pivotal conference uniting key opinion leaders in cancer care. Focused on personalized therapies, iBRCAf presents cutting-edge research, clinical trials, and advancements in multi-cancer early detection, residual disease testing, molecular tumor characterization, targeted therapy selection, biomarkers, genomics-enabled trials, and immunotherapy. The event serves as a platform for in-depth discussions on integrating molecular testing into patient care. iBRCAf emerges as a crucial forum driving progress in cancer research, offering insights that shape the future of tailored treatment approaches for individuals affected by BRCA mutations and beyond.
Featuring Industry Partners & Products
On behalf of the International BRCA Forum (iBRCAf), we would like to welcome you to Singapore for the 8th edition on 20 July, 2024 which will be held as LIVE & IN-PERSON event.
Our initiative of jointly hosting the International BRCA Forum in conjunction with the Young Women’s Forum (YWF) is to inter-connect and discuss the latest data on BRCA, germline genetics, associated hereditary breast and ovarian cancer.
We hope the discussion will provide insights form international experts and local regional practices in the management, counselling, assessment, and treatment plan for patients.
Growth of this niche meeting has only been possible with extended support & vested interest from core groups, institutes, and organizations on a year-on-year basis and has helped us realize our quest in BRCA mutation studies.
We thank all of you for joining the journey with us.
We welcome you to Singapore to learn and network with your colleagues & peers.
WHO SHOULD ATTEND
2024 Partners & Sponsors
Special thanks to the support, involvement and active contribution of our Partners and Sponsors.